Journals / Klinik Psikiyatri Dergisi / 2020 / Cilt: 23 - Sayı: 2

Infertility after long-acting paliperidone palmitate treatment: a case report

Uzun etkili paliperidon palmitat kullanımı sonrası gelişen infertilite: Olgu sunumu

Pages
236–238
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we aimed to present a patient who had severe benefit from long-acting antipsychotic treatment of paliperidone palmitate, but developed hyperprolactinemia during follow-up and the change in prolactin levels back to normal after changing the treatment to long-acting aripiprazole.national emergency transplant list.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hyperprolactinemia is a common side effect of antipsychotic treatments.
📊
Key Findings & Data:Conventional antipsychotics increase prolactin secretion due to their strong D2 receptor antagonism and long-term dependence on the receptor.
💡
Conclusion & Impact:In this study, we aimed to present a patient who had severe benefit from long-acting antipsychotic treatment of paliperidone palmitate, but developed hyperprolactinemia during follow-up and the change in prolactin levels back to normal after changing the treatment to long-acting aripiprazole.national emergency transplant list.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hyperprolactinemia is a common side effect of antipsychotic treatments. Conventional antipsychotics increase prolactin secretion due to their strong D2 receptor antagonism and long-term dependence on the receptor. Among atypical antipsychotics, risperidone and amisulpride are known to increase prolactin levels as typical antipsychotics. 9-OH risperidone (paliperidone), the active metabolite of risperidone; due to its similar receptor effect profile, it may cause prolactin elevation. Hyperprolactinemia may occur due to the use of paliperidone palmitate. Hyperprolactinemia can lead to galactorrhea, amenorrhea, sexual dysfunction, gynecomastia, hirsutism, and infertility. In patients with hyperprolactinemia, other antipsychotics may be used or aripiprazole may be added to the treatment. In this study, we aimed to present a patient who had severe benefit from long-acting antipsychotic treatment of paliperidone palmitate, but developed hyperprolactinemia during follow-up and the change in prolactin levels back to normal after changing the treatment to long-acting aripiprazole.national emergency transplant list.

Özet

Hiperprolaktinemi, antipsikotik tedavilerin sık görülen yan etkilerindendir. Konvansiyonel antipsikotikler güçlü D2 reseptör antagonizması yaptıkları ve reseptöre uzun süre bağlı kaldıkları için prolaktin salgısını artırırlar. Atipik antipsikotikler arasında ise risperidon ve amisülpiridin prolaktin seviyesini tipik antipsikotikler gibi artırdığı bilinmektedir. Risperidonun aktif metaboliti olan 9-OH risperidon (paliperidon); benzer reseptör etki profiline sahip olması nedeniyle prolaktin yüksekliğine neden olabilmektedir. Paliperidon palmitat kullanımına bağlı olarak hiperprolaktinemi görülebilir. Hiperprolaktinemi galaktore, amenore, cinsel işlev bozukluğu, jinekomasti, hirşutizm, ve infertiliteye yol açabilir. Hiperprolaktinemi gelişen hastalarda başka bir antipsikotiğe geçilebileceği gibi, tedaviye aripiprazol de eklenebilir. Biz de aşağıda paliperidon palmitat uzun etkili antipsikotik tedavisinden ciddi fayda gören fakat takipleri sırasında hiperprolaktinemi gelişen ve tedavinin uzun etkili aripiprazol ile değişmesi ile prolaktin seviyeleri normal düzeye dönen bir hastayı sunmayı amaçladık.

🔖

Cite This Article

UĞUR, K., YILDIZ, S. (2020). Infertility after long-acting paliperidone palmitate treatment: a case report. Klinik Psikiyatri Dergisi, Cilt: 23 - Sayı: 2, 236–238. https://ajindex.com/articles/175217

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Kinon BJ, Gilmore JA, Liu H, Halbreich UM. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Psychoneuroendocrinology 2003;28:55-68
  2. Haddad PM, Wiek A. An antipsychotic-induced hyperprolactinemia: mechanisms, clinical features and management. Drugs 2004;64:2291-314
  3. Knegtering H, van der Moolen AE, Castelein S, Kluiter H, van der Bosch RJ. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 2003;28:109-23 4. Madhusoodanan S, Parida S, Jiménez C. Hyperprolactinemia associated with psychotropics. A review. Hum Psychopharmacol Clin Exp 2010;25:281-97
  4. Tadori Y, Forbes RA, McQuade RD, Kikuchi T. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors. Eur J Pharmacol 2008;597:27- 33
  5. Broekhof R, Gosselink MJ, Pijl H, Giltay EJ. The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis. Gen Hosp Psychiatry 2012;34:209
  6. Lee BH, Kim YK, Park SH. Using aripiprazole to resolve antipsychotic induced symptomatic hiperprolactinemia: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:714-7
  7. Bulut SD, Bulut S, Alataş E. Anthypsicotic induced hyperprolactinemia. Current Approaches in Psychiatry 2015;7:109-124 9. Zhao J, Song X, Ai X, et al. Adjunctive aripiprazole treatment for risperidone-induced hyperprolactinemia: an 8-week randomized, open-label, comparative clinical trial. PLoS One. 2015;10:e0139717
  8. Van Kooten M., Arends J, Cohen D. Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection. J Clin Psychopharmacol 2011;31:126-8
  9. Rocha FL, Hara C, Ramos MG. Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1153-4